#IDWeek2022 host city Washington D.C. has made great strides in preventing #HIV .

By how much have new diagnoses decreased since 2011? ViiV Healthcare

For #Media : We’re looking forward to joining infectious disease experts at this year’s conferences. We’ll be sharing data from our innovative #HIV portfolio at #IDWeek2022 and #HIV Glasgow.

Learn more here: viivhealthcare.com

Did you know the World Health Organization (WHO) has declared rising #AntimicrobialResistance as one of the top global public health threats?

At GSK, we’re using science, technology and talent to get ahead of #AMR , together.

#IDWeek2022

We’re investing £1bn over 10 years to accelerate Global Health R&D, focussed on infectious diseases that disproportionately impact the underserved in lower-income countries.

Watch Thomas Breuer, MD, MSc (Epidemiology), our Chief Global Health Officer, making the commitment earlier this year 👇

Our R&D model has evolved: when it comes to tackling infectious diseases, we think about what could have the biggest impact on people’s health.
#IDWeek2022

Which technology has led to the successful development of #vaccines for #infectiousdiseases ?

Learn more here 👉 gsk.com/en-gb/behind-t…

We’re proud to contribute to the ABPI’s newly launched diversity and inclusion in clinical trials hub: gsk.to/3gcdIAy

#DYK RSV causes around the same number of hospitalisations in older adults as seasonal flu each year?

However, advances in science mean we could be on the cusp of finding new solutions.

We’re committed to helping protect those most at increased risk of infectious diseases. #IDWeek2022

Despite many being preventable, infectious diseases are responsible for one in six deaths worldwide.

Our expertise in vaccines and medicines supports our ambition to lead innovation in this area, delivering new solutions for those most at-risk of infection.

#IDWeek2022 starts tomorrow! Stay tuned this week for #infectiousdiseases updates and test your knowledge every morning at 9AM CET on our channel!

#News for #Media : GSK and Tempus announce 3-year collaboration to improve drug targets and clinical trial design. This is key to how we will increase R&D success rate. #AheadTogether

Click to find out more.

Are you ready for #IDWeek2022 this week? We will be joining medical experts and organisations worldwide to raise awareness of #infectiousdiseases and sharing our expertise in disease treatment and prevention

Visit our website for more news and updates. gsk.com/en-gb/

Tony Wood, our Chief Scientific Officer, and John Todd, Professor of Precision Medicine at Oxford University, talk about the role of patients in combatting hard-to-treat diseases like ALS, Alzheimer’s and Parkinson’s #AheadTogether

FT Partner Content

We held a special event at the IMCM, part of our collaboration with Oxford, and shared an update on the initial projects around hard-to-treat diseases like Alzheimer’s and Parkinson’s #AheadTogether FT Partner Content

Last week, WellChild Patron, Prince Harry, The Duke of Sussex met inspirational WellChild Award winners like Henry. The #WellChildAwards , in association with GSK, celebrate inspirational children & those who go the extra mile to support them.

Full video bit.ly/dukeofsussexvi…